|
ArchiveChanges in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy. Fri, 07/16/2010 - 06:33 Author / Source: Yu B, Douglas N, Ferin MJ, Nakhuda GS, Crew K, Lobo RA, et al. Cancer 2010 May 1;116(9):2099-2105. BACKGROUND: Premenopausal women undergoing chemotherapy are at risk for amenorrhea and impaired fertility. The objective of the current study was to assess levels of mullerian inhibitory substance (MIS), estradiol (E2), follicle-stimulating hormone (FSH), and menstrual status, in women undergoing chemotherapy.
A qualitative study of decision-making by breast cancer patients about telling their children about their illness. Fri, 07/16/2010 - 06:20 Author / Source: Yoshida S, Otani H, Hirai K, Ogata A, Mera A, Okada S, et al. Support.Care Cancer 2010 Apr;18(4):439-447. OBJECTIVE: Many breast cancer patients are troubled about telling their school-age children about their illness. However, little attention has been paid to the factors that encourage or discourage them from revealing the illness. This study explored decision-making by breast cancer patients about telling their children about their illness.
Facilitated peer support in breast cancer: a pre- and post-program evaluation of women's expectations and experiences of a facilitated peer support program. Fri, 07/16/2010 - 06:16 Author / Source: Power S, Hegarty J. Cancer Nurs. 2010 Mar-Apr;33(2):E9-16. BACKGROUND: Peer support programs are associated with the provision of emotional, informational, and appraisal support. The benefits of peer support for women with breast cancer include reduced social isolation, enhanced coping, and access to information. |
Search this site:
